Learn More
Medchemexpress LLC MR 409 | 1445155-39-4 | 99.5% | 3395.91 | 1 MG

Supplier: Medchemexpress LLC HYP33041MG
MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist for research use only. It demonstrates neuroprotective effects by enhancing endogenous neurogenesis and inhibits the in vivo growth of lung cancer. This compound can stimulate endogenous neurogenesis and improve tMCAO-induced loss of neuroplasticity.
- Enhances endogenous neurogenesis in cerebral ischemic mice
- Inhibits in vivo growth of lung cancer
- Reduces plasma levels of IL-2, IL-6, IL-10, and TNF-α
- Suppresses p53 expression in bovine pulmonary arterial endothelial cells
- Induces activation of JAK2, STAT3, and ERK1/2
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.